PDS Biotechnology Corporation announces the initial closing of up to $22.3 million PIPE financing, raising $11.3 million. The round was led by Nant Capital with participation from current investors.
PUBLIC · PDSBSep 14, 2026
Amount Raised
$11.3 Million
Round Type
Post-IPO Equity
PrincetonBiotechnologyHealth CareTherapeutics
Investors
Nant Capital, Llc
Description
PDS Biotechnology Corporation has completed the initial closing of its Private Investment in Public Equity transaction. The company raised approximately $11.3 million to repay outstanding indebtedness and for general corporate purposes. The financing includes participants like Nant Capital, LLC.
Company Information
Company
PDS Biotech
Location
Princeton, West Virginia, United States
About
PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed to harness the power of the body's immune system in the fight against cancer and infectious disease.
Fundz sees it the moment PDS Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
PrincetonBiotechnologyHealth CareTherapeutics